Please Login to read the full article.
Clinica
Vermillion shares up 22% on positive ovarian cancer Dx study results
15 September 2011
Madeleine Armstrong
Please Login to read the full article.
Not a subscriber ? Request a FREE Trial
Subscribe to Clinica
RELATED CONTENT
NEWS
Clinica News
- Genomic Vision makes Quest first commercial partner for molecular combing tech
- US Supreme Court hears dosing-test patent case that could decide future of personalised medicine
- Lab21 gains new platform for developing molecular Dx faster
- Genzyme and Veracyte in personalised medicine tie-up for thyroid cancer
Other Informa News
EVENTS
